Potentiation of Fas-induced apoptosis by CRABP2 silencing could be of clinical interest because it persisted in the presence of TNFα and IL1β, two pro-inflammatory stimuli that are present in arthritis and that increase RA FLS survival. This evidence concerns the gene FAS and rheumatoid arthritis.